Alimera Sciences to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
August 31 2017 - 4:01PM
Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the
commercialization and development of prescription ophthalmic
pharmaceuticals, today announced that Rick Eiswirth, President and
Chief Financial Officer, will present at the 19th Annual Rodman
& Renshaw Global Investment Conference to be held September
10-12, 2017 at the Lotte New York Palace Hotel, New York, New York.
Alimera Sciences’ presentation will take place Tuesday, September
12th, 2017 at 3:00pm Eastern Time.
A live broadcast of the conference presentation will be
available. To access the broadcast, go to the "Investor Relations"
section of the Company's website at www.alimerasciences.com. A
replay of the conference presentation will also be available.
About Alimera Sciences, Inc.
www.alimerasciences.com
Alimera, founded in June 2003, is a pharmaceutical company
that specializes in the commercialization and development of
prescription ophthalmic pharmaceuticals. Alimera is presently
focused on diseases affecting the back of the eye, or retina,
because these diseases are not well treated with current therapies
and will affect millions of people in our aging populations.
Alimera’s commitment to retina specialists and their patients is
manifest in Alimera’s product and development portfolio designed to
treat early-and late-stage diseases. For more information, please
visit www.alimerasciences.com.
For press inquiries:
Katie Brazel
for Alimera Sciences
404-317-8361
kbrazel@bellsouth.net
For investor inquiries:
CG Capital
for Alimera Sciences
877-889-1972
investorrelations@cg.capital
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Sep 2023 to Sep 2024